The Potential Dangers of Ketogenic Diets in Kidney Disease
A recent review underscores the possible adverse effects of ketogenic diets, including increased risks for heart disease, cancer, diabetes, and kidney stones.
Diagnosis & Disease Information
Brain Aneurysm Risk Examined in Polycystic Kidney Disease
Aneurysms detected by presymptomatic screening, more frequent in those with hypertension, smoking
Tolvaptan Cleared in US for ADPKD in Adults
Originally approved for hyponatremia, the medication is the first FDA-approved treatment for rapidly progressing autosomal dominant polycystic kidney disease in adults.
Management of ADPKD in 2016 and Beyond
A summary of Dr. Ronald D. Perrone’s presentation that will be given at the National Kidney Foundation’s 2016 Spring Clinical Meetings in Boston, MA.
Recommendations Issued for Tolvaptan Use in ADPKD
ERA-EDTA offers guidance on selecting patients for treatment, when to start the drug, dosing strategies, and other aspects of care.
Polycystic Kidney Disease Raises Atrial Fibrillation Risk
In a study, the arrhythmia was 31% more likely to occur in PKD patients than non-PKD control patients.
Tolvaptan Lowers ADPKD Albuminuria
New findings suggest the medication induces beneficial renal structural changes.
Severe Hyperkalemia Rare Despite Dual RAAS Blockade
Analysis of data from the HALT PKD trial showed that 0% to 0.4% of patients experienced potassium levels above 6.5 mEq/L.
Tolvaptan May Benefit ADPKD Patients with Reduced Kidney Function
After 3 weeks of treatment, total kidney volume decreased and urine volume increased.
Managing Pain in Autosomal Dominant Polycystic Kidney Disease
Review examines etiology of disease and suggests stepwise approach for pain management.
- Loading...
Loading...
Loading... 
Loading...